Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006444 · ClinicalTrials.gov registry record
The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women
A clinical trial of HIV Infections and Papilloma, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 160
- Enrollment target
- 20
- Study locations
NCT00006444: Completed study of HIV Infections and Papilloma, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00006444 is a study of HIV Infections and Papilloma that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 160 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (64% lower). The trial reports 20 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00006444, a study of HIV Infections and Papilloma, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to see how often human papillomavirus (HPV) occurs in HIV-infected women who have not taken anti-HIV drugs and to learn whether taking anti-HIV drugs will affect HPV in women. HIV infection increases the risk of getting HPV infection. Findings suggest that HIV infection as well as a weakened immune system may increase the chances of getting HPV. Aggressive anti-HIV medication has been shown to strengthen the immune system. Researchers want to learn whether anti-HIV drugs affect the HPV virus or decrease the chances of getting HPV. This study is important because it may provide important information to help manage a woman's health and to determine a woman's risk for developing problems with the cervix (outer end of the uterus).
Conditions Studied
Study Locations (20)
California
- Children's Hosp of Los Angeles/UCLA Med Ctr - Los Angeles
- Univ of Southern California / LA County USC Med Ctr - Los Angeles
- Los Angeles County - USC Med Ctr - Los Angeles
- UCLA CARE Ctr - Los Angeles
- Univ of California, San Diego - San Diego
- University of California San Francisco - San Francisco
- San Mateo County AIDS Program - Stanford
- Stanford Univ - Stanford
- Willow Clinic - Stanford
Florida
- North Broward Hosp District - Fort Lauderdale
- Univ of Florida Health Science Ctr / Pediatrics - Jacksonville
- Univ of Miami School of Medicine - Miami
- Univ of Miami / Jackson Memorial Hosp - Miami
- Univ of Miami (Pediatric) - Miami
Alabama
- Univ of Alabama at Birmingham - Birmingham
Colorado
- Univ of Colorado Health Sciences Ctr, Denver - Denver
District of Columbia
- Howard Univ Hosp - Washington D.C.
Georgia
- Emory Univ - Atlanta
Hawaii
- Univ of Hawaii - Honolulu
Illinois
- Mt Sinai Hosp Med Ctr / Dept of Pediatrics - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2000-11 |
| Est. Completion | 2005-08 |
What the finished NCT00006444 record still lists
NCT00006444 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (64% lower).
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.
NCT00006444 names 20 study sites across 8 states, led by California, Florida, Alabama.
Frequently Asked Questions
What is clinical trial NCT00006444 about?
NCT00006444 is a clinical study titled "The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women". The purpose of this study is to see how often human papillomavirus (HPV) occurs in HIV-infected women who have not taken anti-HIV drugs and to learn whether taking anti-HIV drugs will affect HPV in women. HIV infection increases the risk of getting HPV infection. Findings suggest that HIV infection...
What is the current status of trial NCT00006444?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2000-11. Estimated completion is 2005-08.
What conditions does trial NCT00006444 study?
This clinical trial studies the following conditions: HIV Infections, Papilloma.
Who is sponsoring clinical trial NCT00006444?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00006444 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00006444's enrollment target sits among peer trials
160 204th of 542 higher than 338 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia